ClinicalTrials.Veeva

Menu

Diagnostic Performance of 18-FDG PET-CT Scores for the Diagnosis of Polymyalgia Rheumatica (RHUMATEP)

R

Regional University Hospital Center (CHRU)

Status

Not yet enrolling

Conditions

18-FDG
Positron-emission Tomography
Inflammatory Rheumatism

Study type

Observational

Funder types

Other

Identifiers

NCT06558357
29BRC24.0172 - RHUMATEP

Details and patient eligibility

About

Study of the diagnostic performance of 18-FDG PET scores in Polymyalgia rheumatica and comparaison with others inflammatories diseases.

Full description

Polymyalgia Rheumatica is difficult to diagnostic because symptoms are non specific and many diseases can be differential diagnosis (cancer, infections, others rheumatisms...).

PET-CT is more often used to help for diagnostic of inflammatory disease, and particularly inflammatory rheumatism.

Some scores have been described to harmonize the diagnosis of Polymyalgia rheumatica.

The aim of this study is to evaluate the diagnostic performance of 18-FDG PET scores in Polymyalgia rheumatica and compared with others inflammatories diseases such as ankylosing spondylarthritis.

This is a multicentric retrospective study.

Enrollment

210 estimated patients

Sex

All

Ages

18 to 110 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Having 18-FDG PET-CT between 2012 and 2024
  • Diagnosis of inflammatory rheumatism by specialist doctor
  • Adult without opposition to use there data for research
  • Affiliate to social security system

Exclusion criteria

  • Refusal participation
  • Patient under juridic protection

Trial contacts and locations

1

Loading...

Central trial contact

Solène QUERELLOU; Chloé QUERE

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems